BR9711812A - EsterÄides como estimuladores neuroqu¡micos do ÄrgÆo vomeronasal para aliviar os sintomas de pms e ansiedade - Google Patents

EsterÄides como estimuladores neuroqu¡micos do ÄrgÆo vomeronasal para aliviar os sintomas de pms e ansiedade

Info

Publication number
BR9711812A
BR9711812A BR9711812A BR9711812A BR9711812A BR 9711812 A BR9711812 A BR 9711812A BR 9711812 A BR9711812 A BR 9711812A BR 9711812 A BR9711812 A BR 9711812A BR 9711812 A BR9711812 A BR 9711812A
Authority
BR
Brazil
Prior art keywords
pms
steroids
anxiety
relieve symptoms
vomeronasal organ
Prior art date
Application number
BR9711812A
Other languages
English (en)
Inventor
Clive L Jennings-White
David L Berliner
Nathan W Adams
Monti Luis Bloch
Original Assignee
Pherin Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/686,092 external-priority patent/US6057439A/en
Application filed by Pherin Pharm Inc filed Critical Pherin Pharm Inc
Publication of BR9711812A publication Critical patent/BR9711812A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/002—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 13 (17)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/005—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 16 (17)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BR9711812A 1996-07-23 1997-07-23 EsterÄides como estimuladores neuroqu¡micos do ÄrgÆo vomeronasal para aliviar os sintomas de pms e ansiedade BR9711812A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/686,092 US6057439A (en) 1994-08-04 1996-07-23 Steroids as neurochemical stimulators of the VNO to alleviate symptoms of PMS and anxiety
US72586296A 1996-10-04 1996-10-04
PCT/US1997/013035 WO1998003207A1 (en) 1996-07-23 1997-07-23 Steroids as neurochemical stimulators of the vno to alleviate symptoms of pms and anxiety

Publications (1)

Publication Number Publication Date
BR9711812A true BR9711812A (pt) 1999-08-24

Family

ID=27103741

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9711812A BR9711812A (pt) 1996-07-23 1997-07-23 EsterÄides como estimuladores neuroqu¡micos do ÄrgÆo vomeronasal para aliviar os sintomas de pms e ansiedade

Country Status (15)

Country Link
EP (1) EP0914165B1 (pt)
JP (1) JP4450435B2 (pt)
KR (1) KR20000067970A (pt)
CN (1) CN1226837A (pt)
AT (1) ATE342721T1 (pt)
AU (1) AU726625B2 (pt)
BG (1) BG103115A (pt)
BR (1) BR9711812A (pt)
CA (1) CA2260253A1 (pt)
DE (1) DE69736833T2 (pt)
ES (1) ES2273374T3 (pt)
NO (1) NO990305L (pt)
NZ (1) NZ333671A (pt)
PL (1) PL331357A1 (pt)
WO (1) WO1998003207A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922699A (en) * 1996-06-07 1999-07-13 Pherin Corporation 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function
FR2791572A1 (fr) * 1999-03-31 2000-10-06 Adir Utilisation d'hormones sexuelles pour l'obtention d'une composition pharmaceutique nasale utile pour le traitement des saignements uterins indesirables
AU1261501A (en) * 1999-12-06 2001-06-18 Stanley L. Gore Compositions and methods for intranasal delivery of active agents to the brain
US6555531B1 (en) 1999-12-30 2003-04-29 Pherin Pharmaceuticals, Inc. Weight promoting composition, method, and product
US8309539B2 (en) 2005-09-09 2012-11-13 Pherin Pharmaceuticals, Inc. Acute treatment of social phobia
US20090258040A1 (en) * 2008-04-09 2009-10-15 Pherin Pharmaceuticals, Inc. Steroid treatment for hot flashes
ES2625778T3 (es) * 2012-12-28 2017-07-20 Pherin Pharmaceuticals, Inc. Uso de pregn-4-en-20-in-3-ona para el tratamiento de trastornos depresivos
EP3955933B1 (en) * 2019-04-15 2023-11-29 Vistagen Therapeutics, Inc. Treatment of migraine
WO2021080880A1 (en) * 2019-10-25 2021-04-29 Covey Douglas Nmdar inhibiting agents and gabaar potentiating agents and uses thereof
CN112608358A (zh) * 2020-12-29 2021-04-06 北京大学 一种促进花粉萌发的化合物及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208227A (en) * 1987-08-25 1993-05-04 University Of Southern California Method, compositions, and compounds for modulating brain excitability
US5969168A (en) * 1991-01-07 1999-10-19 Pherin Corporation Androstanes for inducing hypothalamic effects
WO1994028904A1 (en) * 1993-06-15 1994-12-22 Pherin Corporation Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
ATE253365T1 (de) * 1993-06-15 2003-11-15 Pherin Pharm Inc Estrensteroide als neurochemische initiatoren einer veränderung der hypothalmusfunktion beim menschen und verwandte pharmazeutische präparate
US5792757A (en) * 1994-08-04 1998-08-11 Pherin Pharmaceuticals 19-nor-pregnane steroids as neurochemical initiators of change in human hypothalamic function
US5563131A (en) * 1994-08-04 1996-10-08 Pherin Corporation Pregnane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
CA2199044A1 (en) * 1994-09-29 1996-04-04 Pherin Corporation Novel estrenes for inducing hypothalamic effects
US5922699A (en) * 1996-06-07 1999-07-13 Pherin Corporation 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function

Also Published As

Publication number Publication date
KR20000067970A (ko) 2000-11-25
EP0914165B1 (en) 2006-10-18
EP0914165A4 (en) 2004-01-21
NO990305L (no) 1999-03-22
BG103115A (en) 1999-09-30
JP2000513000A (ja) 2000-10-03
DE69736833T2 (de) 2007-05-24
AU3963797A (en) 1998-02-10
DE69736833D1 (de) 2006-11-30
CA2260253A1 (en) 1998-01-29
PL331357A1 (en) 1999-07-05
EP0914165A1 (en) 1999-05-12
WO1998003207A1 (en) 1998-01-29
ATE342721T1 (de) 2006-11-15
NO990305D0 (no) 1999-01-22
NZ333671A (en) 2000-07-28
CN1226837A (zh) 1999-08-25
JP4450435B2 (ja) 2010-04-14
ES2273374T3 (es) 2007-05-01
AU726625B2 (en) 2000-11-16

Similar Documents

Publication Publication Date Title
NZ312303A (en) Novel nor-pregnanes for inducing hypothalamic effects
NO985975L (no) Blandinger og fremgangsmÕter for frembringelse av farmakologisk aktive preparater og anvendelser derav
MD1920F2 (ro) Compoziţie şi metodă de profilaxie sau frânare a debutului bolii Alzheimer
NO975334D0 (no) Anvendelse av flavanolignaner for fremstilling av medikamenter med antiproliferativ aktivitet i uterus, ovarium og bryst
MY131522A (en) PHARMACEUTICAL COMPOSITION AND USES FOR ANDROST-5-ENE-3ß,17ß-DIOL
BR9711812A (pt) EsterÄides como estimuladores neuroqu¡micos do ÄrgÆo vomeronasal para aliviar os sintomas de pms e ansiedade
CA2440605A1 (en) Methods for treating stress disorders using glucocorticoid receptor-specific antagonists
BR9307867A (pt) Esteroides de androstano como iniciadores neuroquimicos de alteraçao na funçao hipotalamica humana e composiçoes e métodos farmaceuticos relacionados
BR0008076A (pt) 16-hidroxiestratrienos como estrogênios de efeito seletivo
CA2258177A1 (en) 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function
FI956028A0 (fi) Estreenisteroidit ihmisen hypotalaamisen toiminnan muuttamisen neurokemiallisina initiaattoreina sekä tähän liittyvät farmaseuttiset koostumukset ja menetelmät
MX9700881A (es) Pregnanos y colanos como indicadores neuroquimicos del cambio en la funcion hipotalamica.
RU2004116082A (ru) Применение (11бета, 17 бета)-11-(1,3-бензодиоксол-5-ил)-17-гидрокси-17-(1-пропинил) эстра-4,9-диен-3-она при лечении большого депрессивного расстройства
EP1039931A4 (en) MULTIVALENT RECOMBINANT ANTIBODIES FOR THE TREATMENT OF HUMAN RHINOVIRUS (HRV) INFECTIONS
DE69525181D1 (de) Tnf-rezeptor und steroidhormon dhea in einer kombinationstherapie
BR9816142A (pt) Esteróides de 19-nor-colano como iniciadores neuroquìmicos de mudança na função hipotalâmica humana
MXPA94000705A (es) Esteroides de estreno como iniciadores neuroquimicos del cambio en la funcion hipotalamica humana ycomposiciones farmaceuticas y metodos relacionados.
TW289730B (en) Pharmaceutical composition for alleviating the symptoms of psychoses, depression or anxiety comprising androstene steroids

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A,7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1833 DE 21/02/2006.